Screener
Azenta AZTA Multiomics — Total Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Azenta in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Azenta’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054295
| Line item | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Nine months ended June 30, 2026 | Nine months ended June 30, 2025 |
|---|---|---|---|---|
| Significant Business Line | ||||
| Multiomics | $72,889 | $66,235 | $203,811 | $196,054 |
| Core Products (1) | 47,682 | 45,663 | 139,589 | 143,177 |
| Sample Repository Services | 40,607 | 31,957 | 111,215 | 95,398 |
| Total revenue | $161,178 | $143,855 | $454,615 | $434,629 |
Item 1. Financial Statements
FAQ
- What is Azenta's multiomics — total revenue?
- Azenta (AZTA) reported multiomics — total revenue of $72.89M in Q2 2026.
- How has Azenta's multiomics — total revenue changed year-over-year?
- Azenta's multiomics — total revenue increased by 10.0% year-over-year, from $66.24M to $72.89M.
- What is the long-term trend for Azenta's multiomics — total revenue?
- Over 3 years (2022 to 2025), Azenta's multiomics — total revenue has grown at a 2.4% compound annual growth rate (CAGR), from $250.94M to $269.23M.
- What does multiomics — total revenue mean?
- The total gross income generated from the sale of goods and services within the Multiomics segment, excluding applicable taxes. This metric serves as a primary indicator of market demand and the segment's ability to capture value from its genomic and multiomics service offerings. Growth in this figure reflects successful commercial execution and market penetration.
Ask your AI about Azenta's multiomics — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude